对患有声神经瘤的患者进行治疗计划
Andrew J Fishman1,2,3,4, Oskar Rosiak5, Arnaldo Rivera1
1Department of Otolaryngology-Head & Neck Surgery, University of Missouri, Columbia, MO, United States.
Frontiers in oncology
|November 24, 2025
概括
声神经瘤 (AN) 管理需要个性化治疗计划,平衡瘤特征与患者年龄和听力等因素. 治疗选择包括观察,手术和放射性手术,治疗后的康复至关重要.
科学领域:
- 神经瘤学神经瘤学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 神经外科 神经外科
背景情况:
- 声神经瘤 (AN) 是一种良性静脉质神经瘤,通过先进的成像检测可以提高检测能力.
- 对AN的治疗决定是复杂的,需要根据瘤和患者因素制定个性化计划.
研究的目的:
- 审查声神经瘤的当前管理策略.
- 为专家提供指导,以优化AN患者的治疗计划.
主要方法:
- 综合当前研究和临床专业知识的文献综述.
- 对治疗方案的分析:观察,微手术和立体射线手术.
- 考虑患者特定的因素:年龄,瘤大小,听力和前庭功能.
主要成果:
- 治疗选择 (观察,手术,放射性手术) 取决于瘤的特征和患者的个人资料.
- 保护听力是一个关键的考虑因素,影响手术方法的选择.
- 在治疗后,尤其是手术后,静脉管康复非常重要.
结论:
- 声神经瘤管理必须是个性化的,整合多学科专业知识.
- 量身定制的治疗计划旨在优化功能结果和生活质量.
- 需要进一步的研究来完善治疗算法并增强功能恢复.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...